105 related articles for article (PubMed ID: 11847536)
1. Evaluation of Binding Equation Method for Unbound Serum Concentration Prediction of Valproic Acid in Polytherapy Pediatric Patients with Epilepsy.
Kodama Y; Kuranari M; Kodama H; Ashikari Y; Fujii I; Takeyama M
Am J Ther; 1995 Feb; 2(2):106-111. PubMed ID: 11847536
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of unbound serum carbamazepine and carbamazepine-10,11-epoxide concentration prediction methods in polytherapy adult patients with epilepsy.
Kodama Y; Kuranari M; Fujii I; Kodama H; Takeyama M
Am J Ther; 1996 Oct; 3(10):699-707. PubMed ID: 11862225
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
[TBL] [Abstract][Full Text] [Related]
4. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
5. Prediction of unbound serum valproic acid concentration by using in vivo binding parameters.
Kodama Y; Kuranari M; Tsutsumi K; Kimoto H; Fujii I; Takeyama M
Ther Drug Monit; 1992 Oct; 14(5):349-53. PubMed ID: 1448839
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
J Pharm Sci; 1995 Jul; 84(7):835-9. PubMed ID: 7562433
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.
Kodama Y; Kuranari M; Kodama H; Zaizen T; Yukawa E; Fujii I; Takeyama M
J Pharm Pharmacol; 1996 Oct; 48(10):1068-72. PubMed ID: 8953510
[TBL] [Abstract][Full Text] [Related]
8. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
9. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
[TBL] [Abstract][Full Text] [Related]
11. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of single-point phenytoin dosage prediction methods in pediatric patients.
Yukawa E; Higuchi S; Aoyama T
J Pharmacobiodyn; 1988 Nov; 11(11):736-43. PubMed ID: 3236206
[TBL] [Abstract][Full Text] [Related]
13. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
[TBL] [Abstract][Full Text] [Related]
14. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y
J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614
[TBL] [Abstract][Full Text] [Related]
15. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.
Gidal BE; Pitterle ME; Spencer NW; Maly MM
J Clin Pharm Ther; 1995 Aug; 20(4):215-9. PubMed ID: 8557785
[TBL] [Abstract][Full Text] [Related]
16. Comparison of single-point phenytoin dosage prediction techniques.
Yukawa E; Higuchi S; Ohtsubo K; Aoyama T
J Clin Pharm Ther; 1988 Aug; 13(4):293-305. PubMed ID: 3235480
[TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of pediatric population parameter of slow-releasing preparation of sodium valproate].
Yasuda K; Sugita K; Nakasa H; Niimi H
No To Hattatsu; 1995 Jul; 27(4):282-5. PubMed ID: 7612288
[TBL] [Abstract][Full Text] [Related]
18. A novel method for predicting the unbound valproic acid concentration.
Ishikawa M; Uchida M; Asakawa T; Suzuki S; Yamazaki S; Shiko Y; Kawasaki Y; Suzuki T; Ishii I
Drug Metab Pharmacokinet; 2023 Jun; 50():100503. PubMed ID: 37080137
[TBL] [Abstract][Full Text] [Related]
19. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.
Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M
Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
